Mechanism of Inflammatory Storm Induced by Novel Coronavirus Pneumonia and Intervention Measures of Traditional Chinese Medicine

Bei-jin LI; Xiao LI; Jia-rui XUE; Meng-meng ZHANG; Xin-xue ZHANG; Yan-hua SUN; Zong-jiang ZHAO

doi:10.13422/j.cnki.syfjx.20201323

您当前的位置：

首页 >

文章列表页 >

Mechanism of Inflammatory Storm Induced by Novel Coronavirus Pneumonia and Intervention Measures of Traditional Chinese Medicine

Topic on Epidemic Resistance | 更新时间：2020-08-11

- Mechanism of Inflammatory Storm Induced by Novel Coronavirus Pneumonia and Intervention Measures of Traditional Chinese Medicine
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 13, Pages: 32-38(2020)
- 作者机构：
  
  1.北京市朝阳区崔各庄社区卫生服务中心，北京100103
  2.北京中医药大学，北京 100029
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20201323
  CLC： R22;R242;R2-031;R287
- Published Online：19 March 2020，
  
  Published：05 July 2020
- 稿件说明：
移动端阅览
李贝金,李潇,薛嘉睿等.新冠肺炎炎症风暴的机制探讨及中医药的干预作用[J].中国实验方剂学杂志,2020,26(13):32-38.

LI Bei-jin,LI Xiao,XUE Jia-rui,et al.Mechanism of Inflammatory Storm Induced by Novel Coronavirus Pneumonia and Intervention Measures of Traditional Chinese Medicine[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(13):32-38.
李贝金,李潇,薛嘉睿等.新冠肺炎炎症风暴的机制探讨及中医药的干预作用[J].中国实验方剂学杂志,2020,26(13):32-38. DOI： 10.13422/j.cnki.syfjx.20201323.

LI Bei-jin,LI Xiao,XUE Jia-rui,et al.Mechanism of Inflammatory Storm Induced by Novel Coronavirus Pneumonia and Intervention Measures of Traditional Chinese Medicine[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(13):32-38. DOI： 10.13422/j.cnki.syfjx.20201323.

摘要

新型冠状病毒肺炎（新冠肺炎，COVID-19）部分患者在疾病发展过程中因炎症风暴的发生而出现病情的急剧加重，并发急性呼吸窘迫、多器官功能衰竭等严重并发症，预后不良，死亡率较高。对于炎症风暴，目前西医多采取糖皮质激素、营养支持、人工通气辅助等措施。人工肝、血液净化疗法、体外膜肺氧合等技术的日益成熟，也在一定程度上降低了患者死亡率，但因设备要求较高等诸多条件限制，尚未得到广泛开展。从中医角度看，COVID-19基本病机为疫毒外侵，肺脾受邪，损伤正气，病理性质涉及湿、热、毒、瘀、虚。病情发展至炎症风暴阶段，邪盛正虚，出现邪毒闭肺、毒扰心神、瘀毒互结与气阴亏虚并见，严重者甚至出现阴竭阳亡的危候。目前已有多项研究显示，多种中草药对病毒性肺炎和细胞因子风暴具有多靶点的免疫调节作用。中医药在炎症风暴发生发展的全过程中均有参与，早期祛邪为主，控制炎症、阻断炎症风暴的发生，降低重症发生率；中期祛邪扶正并进以祛除炎症风暴的病理产物，促进炎症的消散和吸收；后期则以益气固脱、回阳救逆等法挽救生命。该文结合COVID-19炎症风暴的病理生理机制与中医辨证施治理论，总结相关中草药、中药方剂、中药制剂对炎症风暴干预的药理研究，并探讨中医药在炎症风暴不同发展时期的干预措施，以期为临床治疗提供指导。

Abstract

Some patients with corona virus disease-2019 (COVID-19) experienced a severe exacerbation of the disease due to the occurrence of inflammatory storm during the development of the disease. They are complicated with acute respiratory distress

multiple organ dysfunction syndrome and other serious complications

with a poor prognosis and a high mortality. For the inflammation storm

western medicine mostly adopts glucocorticoids

nutritional support

artificial ventilation assistance and other measures at present. The development of artificial liver

blood purification therapy

extracorporeal membrane oxygenation and other technologies have also reduced the mortality of patients to some extent. However

due to the high requirements for equipment

the measures have not yet been widely carried out. From the perspective of traditional Chinese medicine(TCM)

the basic pathogenesis of COVID-19 is epidemic toxin invasion

lung and spleen being affected by pathogens

damaging vital Qi

and pathological properties involving dampness

heat

poison

stasis and deficiency. At the stage of inflammation storm

the pathogens are abundant

while the vital Qi is deficient， and the pathogens occlude lung

and disturb the heart and mind

and blood stasis and toxicity are combined with Qi-Yin deficiency. In severe cases

even both Yin and Yang exhaustion occurs. At present

a number of studies have shown that a variety of Chinese herbal medicines have multi-target immunomodulatory effect on viral pneumonia and cytokine storm. TCM participates in whole process of the occurrence and development of inflammation storm

mainly eliminating pathogens in early stage

controlling inflammation and blocking occurrence of inflammation storm， eliminating pathogens and strengthening the body resistance to eliminate the pathological products of the inflammation storm

and promoting the dissipation and absorption of inflammation in the middle stage， and saving lives in late stage by benefiting Qi and relieving depletion

and restoring Yang and rescuing from collapse. On the basis of pathophysiological mechanism of COVID-19 inflammation storm and the theory of TCM syndrome differentiation and treatment

this paper summarized the pharmacological studies on intervention on inflammatory storm with relevant Chinese herbal medicine

Chinese medicine prescriptions and Chinese medicine preparations

and discussed the intervention measures of TCM in different development stages of inflammatory storm

in expectation of providing the guidance for clinical treatment.

关键词

Keywords

references

李琳 , 杨丰文 , 张伯礼 , 等 . 防控疫情,中医从参与者变成主力军 [J]. 天津中医药大学学报， 2020 , 39 ( 1 ): 1 - 3 .

CUI J , LI F , SHI Z L , et al . Origin and evolution of pathogenic coronaviruses [J]. Nat Rev Microbiol , 2019 , 17 ( 3 ): 181 - 192 .

ZHU N ， ZHANG D Y , WANG W L , et al . A novel coronavirus from patients with pneumonia in China,2019 [J]. N Eng J Med , 2020 ， 382 ( 8 ): 727 - 733 .

ZHOU P , YANG X L , WANG X G , et al . A pneumonia outbreak associated with a new coronavirus of probable bat origin [J]. Nature , 2020 ， doi: 10.1038/s41586-020-2012-7 http://dx.doi.org/10.1038/s41586-020-2012-7 .

中华人民共和国国家卫生健康委员会 . 新型冠状病毒肺炎诊疗方案（试行第七版） [EB/OL]. http://www.gov.cn/zhengce/2020-03/04/content_5486710.html http://www.gov.cn/zhengce/2020-03/04/content_5486710.html , 2020-03-03 / 2020-03-03 .

FERARA J L , ABHYANKAR S , GILLILAND D G . Gytokine storm of graft-versus-host disease: a critical effector role for interleukin-1 [J]. Transplant Proc , 1993 , 25 ( 1/2 ): 1216 - 1217 .

YUEN K Y , WONG S S Y . Human infection by avian influenza A H5N1 [J]. HK Med J , 2005 , 11 ( 3 ): 189 - 199 .

刘倩 , 朱平 . EB病毒相关淋巴细胞增殖病与细胞因子风暴 [J]. 中国实验血液学杂志 , 2013 ， 21 ( 2 ): 498 - 502 .

CASADEVALL A , PIROFSKI L A . Ditch the term pathogen [J]. Nature , 2014 , 516 ( 7530 ): 165 - 166 .

LI C , YANG P , ZHANG Y , et al . Corticosteroid treatment ameliorates acute lung injury induced by 2009 swine origin influenza a(H1N1)virus in mice [J]. PLoS One , 2012 , 7 ( 8 ): 1 - 7 .

IMAI Y , KUBA K , NEELY G G , et al . Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury [J]. Cell , 2008 , 133 ( 2 ): 235 - 249 .

HUANG F , GUO J , ZOU Z , et al . Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients [J]. Nat Commun , 2014 , 5 ( 1 ): 3595 .

MAUAD T , HAJJAR L A , CALLEGARI G D , et al . Lung pathology in fatal novel human influenza a(HINT)infection [J]. Am J Respir Crit Care Med , 2010 , 181 ( 1 ): 72 - 79 .

DENG R , LU M , KORTEWEG C , et al . Distinctly different expression of cytokines and chemokines in the lungs of two H5N1 avian influenza patients [J]. J Patho , 2008 , 216 ( 3 ): 328 - 336 .

XU J , ZHONG S , LIU J , et al . Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis [J]. Clin Infect Dis , 2005 , 41 ( 8 ): 1089 - 1096 .

HUANG K J , SU I J , THERON M , et al . An interferon-y-related cytokine storm in SARS patients [J]. J Med Virol , 2005 , 75 ( 2 ): 185 - 194 .

BAUTISTA E . Clinical aspects of pandemic 2009 influenza A(HlN1)virus infection [J]. N Engl J Med , 2010 , 362 ( 18 ): 1708 - 1719 .

张艳丽，蒋澄宇 . 细胞因子风暴：急性呼吸窘迫综合征中的主宰生命之手 [J]. 生命科学 , 2015 , 27 ( 5 ): 554 - 557 .

XU Z , SHI L , WANG Y , et al . Pathological findings of COVID-19 associated with acute respiratory distress syndrome [J]. Lancet Respir Med , 2020 , doi: 10.1016/S2213-2600(20)30076-X http://dx.doi.org/10.1016/S2213-2600(20)30076-X .

HUANG C , WANG Y , LI X , et al . Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China [J]. Lancet , 2020 , 395 ( 10223 ): 497 - 506 .

RUSSELL C D , MILLAR J E , BAILLIE J K . Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury [J]. Lancet , 2020 , 395 ( 10223 ): 473 - 475 .

王莹丽 , 蒋艳 , 朱瑞芳 , 等 . 全球与中国流感病毒对NAIs耐药性趋势及特征 [J]. 中华医院感染学杂志 , 2020 ， 29 ( 2 ): 272 - 277 .

GAO H N , LU H Z , CAO B , et al . Clinical findings in 111 cases of influenza A(H7N9)virus infection [J]. N Engl J Med , 2013 , 368 ( 24 ): 2277 - 2285 .

LIU X , ZHANG Y , XU X , et al . Evaluation of plasma exchange and continuous veno-venous hemofiltration for the treatment of severe avian influenza A(H7N9):a cohort study [J]. Ther Apher Dial , 2015 , 19 ( 2 ): 178 - 184 .

张伯礼 , 王琦 , 谷晓红 , 等 . 新型冠状病毒肺炎中医诊疗手册 [M]. 北京：中国中医药出版社 , 2020 : 1 - 26 .

徐波 , 范存愈 , 邹义龙 , 等 . 46例新型冠状病毒病中医证候学分析 [J]. 中国实验方剂学杂志 , 2020 , 26 ( 2 ): 1 - 6 .

陈瑞 , 罗亚萍 , 徐勋华 , 等 . 基于武汉地区52例新型冠状病毒肺炎的中医证治初探及典型病案分析 [J]. 中医杂志 , 2020 , doi: 11.2166.R.20200220.1443.002 http://dx.doi.org/11.2166.R.20200220.1443.002 .

孙宏源 , 毕颖斐 , 朱振刚 , 等 . 天津地区88例新型冠状病毒肺炎患者中医证候特征初探 [J]. 中医杂志 , 2020 , doi: 11.2166.R.20200224.0948.004 http://dx.doi.org/11.2166.R.20200224.0948.004 .

毕岩 , 岳冬辉 , 高玉伟 , 等 . 甘露消毒丹对H1N1流感病毒感染小鼠细胞因子的影响 [J]. 中华中医药杂志 , 2014 , 29 ( 12 ): 3950 - 3953 .

刘叶 , 吴智兵 , 林兴栋 , 等 . 蒿芩清胆汤对流感病毒性肺炎湿热证模型小鼠免疫损伤的影响 [J]. 上海中医药大学学报 , 2011 , 25 ( 2 ): 51 - 55 .

王强 , 刘亚欧 , 李兴平 . 银翘散对呼吸道黏膜Th1/Th2细胞因子的影响 [J]. 中成药 , 2013 , 35 ( 1 ): 165 - 167 .

常秀娟 , 张帅 , 江益平 , 等 . 从细胞因子风暴探讨热毒宁注射液抗大鼠急性肺损伤作用机制 [J]. 中草药 , 2015 , 46 ( 2 ): 236 - 239 .

李承羽 , 张晓雨 , 刘斯 , 等 . 血必净注射液治疗新型冠状病毒感染的肺炎(COVID-19)证据基础及研究前瞻 [J/OL]. 世界科学技术—中医药现代化 , 2020 ， doi:11.5699.R.20200217.1242.002 .

许宗颖 , 石少华 , 于瀚 , 等 . 苓桂术甘汤对气道黏液高分泌大鼠IL-1 β 、IL-13、EGF及EGFR基因mRNA表达的影响 [J]. 中医药导报， 2019 , 25 ( 5 ): 43 - 46,50 .

王进 , 乔礼芬 , 李永胜 , 等 . 参附注射液对脂多糖诱导的大鼠肺泡巨噬细胞核因子- κ B的激活和细胞因子产生的影响 [J]. 华中科技大学学报:医学版 , 2009 , 38 ( 1 ): 15 - 18 .

严胜泽 . 太子参多糖对环磷酰胺所致免疫损伤小鼠的保护作用研究 [D]. 福州：福建农林大学 , 2015 .

程燕 , 陈志明 , 李莉 , 等 . 黄芪多糖对脓毒症大鼠心脏功能及炎症因子水平的影响 [J]. 浙江中医药大学学报 , 2018 , 42 ( 5 ): 354 - 359 .

夏文广 , 安长青 , 郑婵娟 , 等 . 中西医结合治疗新型冠状病毒肺炎34例临床研究 [J]. 中医杂志 , 2020 , 61 ( 5 ): 375 - 382 .

方辉 , 杨介钻 , 肖党生 . 探讨微汗法是祛除新型冠状病毒(2019-nCoV)和炎症风暴的基本原则 [J]. 中医临床研究 , 2020 ， doi： 11.5895.R.20200219. 1723.002 http://dx.doi.org/11.5895.R.20200219. 1723.002 .

王玉光 , 齐文升 , 马家驹 , 等 . 新型冠状病毒(2019-nCoV)肺炎中医临床特征与辨证治疗初探 [J]. 中医杂志 , 2020 , 61 ( 4 ): 281 - 285 .

南征 , 王檀 , 仕丽 , 等 . 吉林省新型冠状病毒肺炎中医诊治思路与方法 [J]. 吉林中医药 , 2020 , 40 ( 2 ): 141 - 144 .

薛伯寿 , 姚魁武 , 薛燕星 . 清肺排毒汤快速有效治疗新型冠状病毒肺炎的中医理论分析 [J]. 中医杂志 , 2020 , doi: 11.2166.R.20200216.2004.002 http://dx.doi.org/11.2166.R.20200216.2004.002 .

苗青 , 丛晓东 , 王冰 , 等 . 新型冠状病毒肺炎的中医认识与思考 [J]. 中医杂志 , 2020 , 61 ( 4 ): 286 - 288 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Jiebiao Qingli Decoction Regulates TLR7/MAPK/NF-κB Pathway to Prevent and Treat Pneumonia Induced by IAV Infection

Role of Cytokines and Related Signaling Pathways in Intervention of Chinese Medicine in Radiation-induced Lung Injury： A Review

Shaoyaotang and Its Modified Formulas in Treatment of Ulcerative Colitis： A Review

Immunoregulatory Effect of Jiedu Tongluo Shengjin Prescription on Sjögren's Syndrome Mice Based on Stability of Treg Cells

Visualization of mTOR Pathway Regulated by Traditional Chinese Medicine： A Bibliometric Analysis Based on Multiple Software

Related Author

MING Yu

MA Yichuan

YAO Ruiqi

CHAO Yan

ZHANG Hongchun

SHAO Jiayi

WU Mianhua

MA Yanxia

Related Institution

Clinical Research Center for Respiratory Diseases，China-Japan Friendship Hospital

Beijing Oriental Yunjia Pharmaceuticals Co. Ltd.

Shenzhen Nanshan District Hospital of Traditional Chinese Medicine

Shenzhen Bao'an Authentic Traditional Chinese Medicine Therapy Hospital

Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Sciences

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰